Weekly Tech+Bio Highlights #47: Microsoft AI's Diagnostic Multi-Agent Orchestrator

Also: New Foundation Model for Zero-Shot Antibody Design & The Role of AI in Rare Disease Tech

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: